Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: A multicenter prospective study

BMC Pulmonary Medicine

Volumn 17, Issue 1, 2017, Pages

  Tonelli, Roberto ^a   Cocconcelli, Elisabetta ^d   Lanini, Barbara ^b   Romagnoli, Isabella ^b   Florini, Fabio ^c   Castaniere, Ivana ^a   Andrisani, Dario ^a   Cerri, Stefania ^a   Luppi, Fabrizio ^a   Fantini, Riccardo ^a   Marchioni, Alessandro ^a   Beghè, Bianca ^a   Gigliotti, Francesco ^b   Clini, Enrico M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Respiratory Pathophysiology Unit   (Italy)

^c Villa Pineta Hospital   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endurance test; Endurance time; Functional performance; Interstitial lung diseases; Pulmonary rehabilitation

Indexed keywords

CARBON MONOXIDE;

AGE; AGED; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; DIFFUSE LUNG CAPACITY FOR CARBON MONOXIDE; DISEASE SEVERITY; DYSPNEA; ENDURANCE; EXERCISE; FEMALE; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MALE; MEDICAL RESEARCH COUNCIL SCALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RESPIRATORY TRACT PARAMETERS; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CLINICAL TRIAL; EXERCISE TOLERANCE; FATIGUE; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY; WALK TEST;

AGED; DYSPNEA; EXERCISE; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; VITAL CAPACITY; WALK TEST;

EID: 85030850125     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-017-0476-5     Document Type: Article

References (31)

1. Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.
2. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301-15.
3. Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, Khalil N, Collard HR, Garvey C. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014;108(1):203-10.
4. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health- related quality of life in patients with interstitial lung disease. Chest. 1999;116:1175-82.
5. From the global strategy for the diagnosis, management and prevention of COPD. Global initiative for chronic obstructive lung disease (GOLD); 2017. Available from: http://www.goldcopd.org.
6. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390-413.
7. Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S, Nishimura K, Taniguchi H. Effects of rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13:394-9.
8. Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayon C, Shariat C, Collard HR. Pulmonary rehabilitation in interstitial lung disease. Benefits and predictor of response. Chest. 2009;135:442-7.
9. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549-54.
10. Naji NA, Connor MC, Donnelly SC, McDonnell TJ. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardpulm Rehabil. 2006;26(4):237-43.
11. Salhi B, Troosters T, Behaegel M, Joos G, Derom E. Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest. 2009;137(2):273-279.
12. Huppmann P, Sczepanski B, Boensch M, Winterkamp S, Schönheit-Kenn U, Neurohr C, Behr J, Kenn K. Effects of in-patient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J. 2013;42:444-53.
13. Holland AE, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev. 2008;4:CD006322.
14. Holland AE, Hill CJ, Glaspole I, Goh N, McDonald CF. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med. 2012;106:429-35.
15. Kenn K, Gloeckl R, Behr J. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis - a review. Respiration. 2013;86:89-99.
16. American Thoracic Society. European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277-304.
17. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511-22.
18. Quanjer PH, Tammeling GJ, Cotes JE, Pederson OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for steel and coal. Official statement of the European Respiratory Society. Rewiew. Eur Respir J. 1993;16(suppl 9):5-40.
19. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684-91.
20. American Respiratory Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-7.
21. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982;14:377-87.
22. Medical Research Council. Committee on reasearch into chronic bronchitis. Instruction for use of the questionnaire on respiratory symptoms: Devon WJ, Holman; United Kingdom; 1966.
23. Carone M, Bertolotti G, Anchisi F, Zotti AM. The St George's Respiratory Questionnaire (SGRQ): Italian version. Rassegna Patol App Respir. 1999;14:31-7.
24. Patel AS, Siegert R, Brignall K, et al. S133 The assessment of health related quality of life in interstitial lung disease with the King's brief interstitial lung disease questionnaire (K-BILD). Thorax. 2011;66:A61.
25. Nishyiama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Nishimura K. Health-related quality of life in patients with idiopatic pulmonary fibrosis: what is the main contributing factor? Respir Med. 2005;99:408-14.
26. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 Suppl):4S-2.
27. Swigris JJ, Wamboldt FS, Behr J, et al. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax. 2010;65:173-7.
28. Lacasse Y, Goldstein R, Lasseron TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793.
29. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;(10):CD006322.
30. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16:1196-202.
31. Holland AE, Dowman L, Fiore LJ, Brazzale D, Hill CJ, McDonald CF. Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test. BMC Pulm Med. 2014;14:136.